Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEsure Group Regulatory News (ESUR)

  • There is currently no data for ESUR

Interim Management Statement

13 Nov 2013 07:00

RNS Number : 8651S
esure Group plc
13 November 2013
 



esure Group plc

 

Interim Management Statement for the nine months to 30 September 2013

 

13 November 2013

 

On track to meet market expectations for the full year despite challenging market conditions

 

Highlights

 

· Gross written premiums year-to-date up 4.8% to £427.0m (YTD Q3 2012: £407.6m) - motor up 4.8% and home up 4.2%

· Gross written premiums for Q3 up 1.7% to £161.5m (Q3 2012: £158.8m) - motor up 1.8% and home up 1.3%

· Total in-force policies at 30 September 2013 of 1.906 million (FY 2012: 1.759 million)

· Additional Services Revenue1 ("ASR") year-to-date up 0.4% to £79.3m (YTD Q3 2012: £79.0m)

- ASR excluding Claims Income up 7.5% to £72.7m (YTD Q3 2012: £67.6m)

· The financial position remains strong and the Group remains debt-free.

 

 

Stuart Vann, Chief Executive Officer of esure Group plc, commented:

 

"Gross written premiums grew by 4.8% in the first nine months of the year, with growth in Q3 broadly flat, in line with the guidance we provided at the half year. This has been achieved against a backdrop of a very competitive UK motor market.

 

"We continue to focus on disciplined underwriting and maintaining our high customer retention rates. This is particularly reflected in the Sheilas' Wheels book where our customers continue to see the benefits from gender-neutral pricing. We also continued cautiously to re-enter certain segments of the motor market that we exited between 2009 and 2011.

 

"ASR excluding Claims Income has grown proportionately in line with the growth in policy count and I am pleased with the initial performance of the "Just in Case" product that we launched during August.

 

"The estimated cost of the St Jude's Day storm is within the normal range of anticipated weather for Q4.

 

"We remain on track to meet market expectations for the full year."

 

Business Update

 

Motor premiums were up 1.8% in Q3, reflecting esure Group plc's ("the Group's") decision to maintain pricing and underwriting discipline despite continuing tough market conditions. The Group has focused on retaining existing customers, with an improvement in the overall retention rate compared to Q3 2012.

 

The Group continues to take a cautious and conservative approach to growth in those segments of the UK motor market from which it withdrew during the personal injury phenomenon. As was indicated at the interim results in August, it is still too soon to judge the full impact of the civil justice reforms and LASPO2, and the Group will continue to monitor developments.

 

The Group also remains focused on writing low-risk home business in what is also a highly competitive market. The home book has continued to grow during Q3, with home premium up 4.2% year-to-date, driven by targeted pricing in the core policy and tactical price reductions in home additional insurance products.

 

 

 

For further information:

 

Investor Relations: Nick Wrighton - Head of Corporate Finance & Investor Relationst: 01737 235164e: nick.wrighton@esure.com

 

esure Group Corporate Media Enquiries: Adrian Webb - Head of Marketing & Corporate Communicationst: 01737 641000e: adrian.webb@esure.com

 

Chris Barrie/Grant Ringshaw - Corporate Press Enquiries, Citigate Dewe Rogerson

t: 0207 638 9571

e: esure@citigatedr.co.uk

 

Notes

 

1. Additional Services Revenue includes four main components: (i) sales of underwritten and non-underwritten additional insurance products to motor and home insurance customers; (ii) installment interest on premium payment plans; (iii) policy administration fees; and (iv) legal panel membership fees and fees generated from the appointment of firms used during the claims process, including vehicle repair, car hire and medical suppliers where applicable in the relevant period ("Claims Income"). Additional Services Revenue is stated before the deduction of any internal costs of acquisition or administration. Non-underwritten additional insurance products revenue represents the commission margins for the Group generated from sales of such products. Underwritten Additional Services Revenue is stated after the deduction of claims costs. Additional Services Revenue is a non-IFRS measure which management uses to evaluate Group performance. It may not be comparable with similarly titled measures used by other companies

 

2. The Legal Aid, Sentencing and Punishment of Offenders Act 2012

 

 

Cautionary statement

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Group or industry results to differ materially from any future events, results, performance or achievements expressed or implied by such forward-looking statements. Persons receiving this announcement should not place undue reliance on any forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, esure disclaims any obligation or undertaking to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFFUESEFDSESF
Date   Source Headline
7th Jun 20167:00 amRNSAnnouncement of strategic review of Gocompare.com
1st Jun 20168:44 amRNSTotal Voting Rights
20th May 201610:28 amRNSHolding(s) in Company
13th May 20168:56 amRNSResult of AGM
5th May 20167:00 amRNS2016 Q1 Interim Management Statement
27th Apr 20169:40 amRNSNotice of Results
26th Apr 20169:33 amRNSHolding(s) in Company
18th Apr 20169:05 amRNSHolding(s) in Company
8th Apr 20168:41 amRNSAnnual Report and Accounts and Notice of AGM
1st Apr 20167:01 amRNSTotal Voting Rights
1st Apr 20167:00 amRNSBlocklisting Interim Review
18th Mar 20161:05 pmRNSHome Member State
10th Mar 20163:49 pmRNSHolding(s) in Company
8th Mar 20167:00 amRNS2015 Preliminary Results
26th Feb 20168:51 amRNSDirectorate Change
18th Feb 20169:30 amRNSNotice of Results
8th Feb 20168:46 amRNSHolding(s) in Company
4th Jan 20168:21 amRNSTotal Voting Rights
31st Dec 20151:27 pmRNSDirector/PDMR Shareholding
1st Dec 20158:58 amRNSTotal Voting Rights
11th Nov 20157:00 amRNS2015 Q3 Interim Management Statement
16th Oct 20152:46 pmRNSNotice of Results
14th Oct 201511:17 amRNSDirectorate Change
12th Oct 20158:54 amRNSAdditional Listing
1st Oct 20158:16 amRNSBlocklisting Interim Review
14th Aug 20153:20 pmRNSDirector/PDMR Shareholding
12th Aug 201510:48 amRNSDirectorate Change
10th Aug 20157:00 amRNSHalf Yearly Report
31st Jul 20152:45 pmRNSHolding(s) in Company
23rd Jul 20159:25 amRNSNotice of Results
17th Jul 201510:58 amRNSHolding(s) in Company
8th Jun 20159:00 amRNSAdditional Listing
2nd Jun 20159:09 amRNSDirectorate Change
14th May 201511:52 amRNSResult of AGM
7th May 20157:00 amRNSInterim Management Statement
24th Apr 20159:07 amRNSNotice of Results
10th Apr 20159:33 amRNSAnnual Report and Accounts and Notice of AGM
7th Apr 201511:01 amRNSHolding(s) in Company
1st Apr 20151:36 pmRNSBlocklisting Interim Review
31st Mar 20151:10 pmRNSRe: Acquisition
26th Mar 20152:59 pmRNSDirector/PDMR Shareholding
16th Mar 20158:46 amRNSHolding(s) in Company
13th Mar 20159:04 amRNSHolding(s) in Company
11th Mar 20153:45 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSResults for the year ended 31 December 2014
23rd Feb 20154:32 pmRNSRe: Acquisition
29th Jan 201512:41 pmRNSNotice of Results
18th Dec 20144:06 pmRNSPublication of Prospectus
8th Dec 20143:23 pmRNSHolding(s) in Company
8th Dec 20147:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.